Topotecan has significant activity in SCLC, particularly in patients sensitive to prior chemotherapy, with predictable and manageable toxicity. The incorporation of topotecan in combination chemotherapy regimens for future treatment of SCLC is warranted.
No takes yet. Share an insight, caveat, or question.
Ardizzoni et al. (1997) studied this question.